NNNadereh Naderi

Nadereh Naderi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nadereh Naderi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Hossein Montazerghaem

    Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

    4 shared publications
  • Mahsa Rahimzadeh

    Department of Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

    4 shared publications
  • Mahsa Rahimzadeh

    Molecular Medicine Research Center Hormozgan Health Institute Hormozgan University of Medical Sciences Bandar Abbas Iran

    3 shared publications
  • Mahmood Khayatian

    Department of Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

    2 shared publications
  • A Shafizad

    Depatment of Radiation Oncology, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas 7919693116, Iran

    1 shared publication
  • F Arabpour

    Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas 7919693116, Iran

    1 shared publication

Latest Publications

  • Open Access

    Age-Related Changes in the T Helper 17 and Regulatory T Cell-Related Cytokines During Cardiac Surgery

    by Nadereh Naderi, Hossein Montazerghaem, Mahsa Rahimzadeh

    Background: The age-associated dysregulated immune response may partly contribute to the greater mortality and morbidity in elderly patients undergoing cardiopulmonary bypass (CPB). The aim of the present study was to first investigate the possible relation between age and levels of interleukin (IL)-17 and IL-35 in CPB patients. Methods: In general, 90 patients undergoing CPB from February 2018 to March 2019 in Jorjani Heart Center, Bandar Abbas, were enrolled in this cross-sectional study. IL-35 and IL-17A were measured before and 12 hours after CPB using enzyme-linked immunosorbent assay. The relation of age and the mentioned cytokines was assessed in patients0.05). There was a positive correlation between IL-17 and age (r=0.4, P=0.002) in patients older than 70 years. Eventually, IL-35 was negatively associated with age (r=-0.2, P=0.03) in≥70 years patients. Conclusion: These data suggested that the age-related elevation of IL-17A levels, as well as a decline in the IL-35 serum concentration, contributing to the imbalanced pro- and anti-inflammatory response, may play a crucial role in the stronger adverse post-CPB outcomes in the elderly.

  • The Role of Soluble ACE2 as a Prognostic Marker in Severe COVID-19: A Brief Meta-Analysis

    by Mahsa Rahimzadeh, Nadereh Naderi

    Background: The recently emerged novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has posed a serious threat to public health, and there is an urgent need to establish tools that can aid the clinician in the evaluation and management of highrisk patients. This meta-analysis aimed to investigate the potential of sACE2 (soluble angiotensinconverting enzyme 2) as a prognostic biomarker in COVID-19. Method: A comprehensive search of PubMed/MEDLINE, Cochrane, and Google Scholar, was performed until May 26, 2021. Data extraction and quality assessment of the study were independently conducted by the authors. Finally, 6 studies were included in this meta-analysis. Results: ACE-2 serum or plasma levels were compared between COVID-19 patients and healthy controls. ACE-2 level was not significantly different between severe COVID-19 patients and healthy controls (SMD = 1.2; 95% CI: -1.3-1.5; P = 0.86), severe and non-severe COVID-19 patients (SMD = 0.3; 95% CI: -0.06-0.7; P = 0.1), and severe COVID-19 patients and healthy controls (SMD = 0.6; 95% CI: -1.1-2.3; P = 0.5). Conclusions: We cautiously propose that circulating levels of ACE2 cannot be used as a biomarker to assess disease severity in COVID-19 patients.


  • Open Access

    Elevated Levels of Interleukin-21 in Acute Kidney Injury After Cardiopulmonary Bypass Surgery

    by Nadereh Naderi, Mostafa Mohebkiya, Hossein Montazerghaem, Mahmood Khayatian, Mahsa Rahimzadeh

    Background: It is well-established that complications following cardiopulmonary bypass (CPB) such as acute kidney injury (AKI) lead to worse outcomes and higher mortality. Considering the importance of the post-CPB inflammatory cytokine cascade, we first assessed the post-operative interleukin (IL)-21 serum level and its association with AKI development after CPB. Methods: In this experimental before-after study, 40 patients with confirmed CPB-AKI in the Jorjani Heart Center, Bandar Abbas (from January 2017 to September 2018) were compared with 50 non-AKI patients. AKI was defined according to the Acute Kidney Injury Network. The IL-21 serum level was measured using an enzyme-linked immunosorbent assay before and 12 hours after surgery. The association between IL-21 and other variables was evaluated by correlation analyses. Results: The IL-21 serum level was significantly higher post-operation compared to its level before surgery in AKI (21.4±6.3 and 15.7±5.5, P<0.001) and non-AKI (19.1±6.4 and 13.7±6.3, P<0.001) patients, but no significant differences were observed between AKI and non-AKI patients. Age, body mass index, and creatinine were not significantly correlated with the IL-21 serum level 12 hours post operations in AKI and non-AKI subjects. Conclusion: Serum IL-21 concentrations were significantly increased in CPB patients after operation, which may contribute to the post-CPB inflammatory response syndrome. Our data did not confirm any association between increased IL-21 levels and CPB-AKI risk.

  • RORC gene polymorphism is associated with acute kidney injury following cardiac surgery

    by Zeynab Gholamipoor, Mahsa Rahimzadeh, Hossein Montazerghaem, Nadereh Naderi

    Background: Acute kidney injury (AKI) is a common complication of cardiopulmonary bypass (CPB), associated with increased mortality in surgical patients. It is well‐proven that Th17 and its hallmark cytokine, IL‐17, contribute to AKI development. Since the RAR‐related orphan receptor C (RORC) gene is a master regulator of the Th17 differentiation, we aimed to evaluate the association between its polymorphisms, CPB‐AKI and plasma IL‐17 levels among Iranian patients undergoing CPB.Method: Totally, 138 patients undergoing CPB in Bandar Abbas, Iran, were enrolled. The allele and genotype frequencies of the selected SNPs were determined using PCR‐SSP. IL‐17 serum level was determined using an enzyme‐linked immunosorbent assay.Results: Rs9017 GG genotype and G allele were associated with increased risk of CPB‐AKI (OR = 3, 95% CI = 1.4–6.6 and OR = 2.3, 95% CI = 1.3–3.9, respectively) while A allele was protective against the disease (OR = 0.4, 95% CI = 0.3–0.7, p = .02). There was not a statistically significant interaction between the three genotypes of rs9017 and AKI disease with IL‐17 serum level before (p = .9) and after (p = .6) the operation. The IL‐17 serum level before surgery was significantly higher in patients carrying GG genotype compared to GA genotype (p = .017).Conclusion: Our results showed that the rs9017 GG genotype was associated with an increased level of IL‐17 and risk of CBP‐AKI in the Iranian population. Our current results suggest that the rs9017 GG genotype could be a probable predictor of AKI after cardiac surgery.


  • Open Access

    Lack of association between serum IL-25 levels and acute coronary syndrome: a preliminary study

    by Nadereh Naderi, Narges Farshidi, Hossein Farshidi, Hossein Montazerghaem, Mahsa Rahimzadeh

    Purpose   Here, for the first time, the possible association between IL-25 and the risk of acute coronary syndrome (ACS) in Iranian patients was investigated. Material and methods   In this study, serum IL-25 concentrations were measured with an enzyme-linked immunosorbent assay in 88 ACS patients, 40 stable angina pectoris (SAP) patients, and 50 healthy control subjects. Results No significant differences in IL-25 concentrations were observed between SAP (340±168 ng / l), ACS (330±151 ng / l), and control (302±135 ng / l) groups (p=0.5), nor was there a difference among patients with 1, 2, or 3 vessel disease in the SAP and ACS groups. Linear regression analyses revealed that IL-25 was not correlated with coronary artery disease risk factors. Biochemical and demographic variables did not differ significantly among IL-25 quartiles. Conclusion Despite previous murine and human studies showing a protective role of IL-25 in atherosclerosis, our results revealed that IL-25 does not have potential implications for atherosclerosis development and management in humans.

  • Toward an understanding of regulatory T cells in COVID‐19: A systematic review

    by Mahsa Rahimzadeh, Nadereh Naderi

    A more detailed understanding of Treg cells in COVID‐19 infection will broaden our knowledge of the COVID‐19 immunopathology and give us more insight into the curative immune‐based strategies. We systematically searched electronic databases (PubMed, Google Scholar, EMBASE) and identified 18 eligible studies. Despite the inconsistencies between the results, we observed a trend toward decreasing Treg levels in severe COVID‐19 patients. This finding underlines the hypothesis that Tregs play a role in the pathogenesis of COVID‐19. Further studies on Tregs' functional aspects are necessary to illustrate Tregs' potential role in COVID‐19 disease.


  • FOXP3 GENE POLYMORPHISM IS ASSOCIATED WITH BREAST CANCER IN IRANIAN PATIENTS

    by F Arabpour, A Shafizad, M Rahimzadeh, M Norouzian, N Naderi

    Aim: Breast cancer (BC) is one of the leading causes of cancer death among women. Recent studies have characterized FoxP3 as a marker of regulatory T cells and an X-linked tumor suppressor gene, which is involved in the pathogenesis of BC. Therefore, we investigated the potential influence of three single-nucleotide polymorphisms (SNPs) of FoxP3 gene on the development of BC in Iranian women. Materials and Methods: The association between FoxP3 rs2232365, rs3761548 and rs4824747 polymorphisms and BC risk was assessed in 124 BC patients and 198 healthy controls using sequence-specific primers. Results: We identified significant difference of rs3761548 in both allele and genotype frequencies between cases and control groups. Our results showed that individuals carrying FoxP3 rs3761548 AA genotype had about 4.3-fold increased risk of BC compared with CC carriers. No significant association was found between rs3761548C>A polymorphism and clinical outcome parameters (age of onset, tumor size, lymph nodes metastasis, tumor stage, progesterone receptor status, estrogen receptor status, Ki-67 status, HER-2 status and duration of disease). Conclusion: This study has provided the first genetic data on the FoxP3 gene polymorphism in south of Iran and proposes the rs3761548 polymorphism of FoxP3 gene as a risk factor, but not a prognostic marker in the development of BC in Iranian population.


  • Preliminary Report on the Association Between STAT3 Polymorphisms and Susceptibility to Acute Kidney Injury After Cardiopulmonary Bypass

    by Sara Aghakhani Chegeni, Mahsa Rahimzadeh, Hossein Montazerghaem, Mahmood Khayatian, Farzaneh Dasturian, Nadereh Naderi

    Cardiopulmonary bypass-associated acute kidney injury (CPB-AKI) is a well-recognized complication which is clearly linked to increased morbidity and mortality. Due to important role of inflammation in CPB-AKI pathogenesis, we explored the association between polymorphisms in STAT3, an inflammation-associated transcription factor, and the risk of CPB-AKI. In this study, STAT3 rs1053004 and rs744166 polymorphisms were analyzed in 129 patients undergoing coronary artery bypass grafting in Jorjani heart center, Bandar Abbas, Iran. The genotypes were determined using sequence-specific primers (PCR–SSP). Sixty-three patients met the criteria for AKI after cardiac surgery (AKI group). The remaining 66 patients did not develop AKI (non-AKI group). Rs1053004 GG genotype was significantly associated with a decreased risk (OR 0.4, 95% CI 0.17–0.9, P = 0.03) of CPB-AKI. Subgroup analyses revealed that GG genotype has also a protective effect in older patients (Age ≥ 60) (OR 0.19, 95% CI 0.04–0.8, P = 0.01). However, rs744166 did not show any difference between AKI and non-AKI groups. The result of our study for the first time provides evidence that rs1053004 polymorphism is significantly associated with a decreased risk of CPB-AKI in Iranian population, especially in older subjects.